New insights in amyloid beta interactions with human telomerase

Area of Science:

• Molecular Biology
• Neuroscience
• Aging Research

Background:

• Aging is the primary risk factor for Alzheimer's disease (AD).
• Telomeres and telomerase play crucial roles in cellular aging.
• Human telomerase has been implicated in AD pathogenesis.

Purpose of the Study:

• To investigate the effect of amyloid-beta (Aβ) on telomerase activity.
• To elucidate the mechanism by which Aβ influences telomerase.
• To explore the role of Aβ-induced telomerase inhibition in AD and aging.

Main Methods:

• In vitro and in cell assays to measure telomerase activity.
• Analysis of Aβ structure (β-sheet formation) and its effect on telomerase.
• Investigation of Aβ binding to telomeric DNA·RNA hybrids.
• Microscopy to determine intracellular Aβ localization at telomeres.

Main Results:

• Aggregated Aβ (Aβ1-40, Aβ1-42), but not Aβ monomer, inhibited telomerase activity.
• β-sheet structures in Aβ were essential for telomerase inhibition.
• Aβ oligomers bind to telomeric DNA·RNA hybrids, blocking telomerase function.
• Intracellular Aβ localized at telomeres, causing cell senescence and telomere shortening.

Conclusions:

• Aβ oligomers act as natural inhibitors of telomerase.
• Inhibition of telomerase activity by Aβ oligomers may contribute to AD cytotoxicity.
• This finding provides new insights into the relationship between aging and Alzheimer's disease.